Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Pigna

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 23, 2011
Treating statin-intolerant patientsMarcello Arca, Giovanni Pigna
Current Vascular Pharmacology|December 25, 2012
Mechanisms of diabetic dyslipidemia: relevance for atherogenesisMarcello Arca, Giovanni Pigna, Carla Favoccia
Internal and Emergency Medicine|March 8, 2011
Severe coronary and extracoronary atherosclerosis in autosomal recessive hypercholesterolemia detected by whole-body computed tomography angiographyMarcello Arca, Fabiana Quagliarini, Giovanni Pigna, et al.
Atherosclerosis|September 7, 2015
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approachIlenia Minicocci, Cristina Prisco, Anna Montali, et al.
Atherosclerosis|February 11, 2011
The relationship between metabolic syndrome, its components, and the whole-body atherosclerotic disease burden as measured by computed tomography angiographyGiovanni Pigna, Alessandro Napoli, Fulvio Zaccagna, et al.
Metabolism: Clinical and Experimental|October 24, 2007
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemiaMarcello Arca, Anna Montali, Giovanni Pigna, et al.
The American Journal of Cardiology|November 13, 2007
Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery diseaseMarcello Arca, Anna Montali, Sofia Valiante, et al.
The Journal of Clinical Endocrinology and Metabolism|June 5, 2012
Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterizationIlenia Minicocci, Anna Montali, Marius Robert Robciuc, et al.
Journal of the American Heart Association|April 23, 2021
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular EventsLaura D'Erasmo, Ilenia Minicocci, Alessia Di Costanzo, et al.
International Journal of Cardiology|June 1, 2013
Functional and morphological vascular changes in subjects with familial combined hypolipidemia: an exploratory analysisIlenia Minicocci, Vito Cantisani, Eleonora Poggiogalle, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 23, 2011
Treating statin-intolerant patientsMarcello Arca, Giovanni Pigna
Current Vascular Pharmacology|December 25, 2012
Mechanisms of diabetic dyslipidemia: relevance for atherogenesisMarcello Arca, Giovanni Pigna, Carla Favoccia
Internal and Emergency Medicine|March 8, 2011
Severe coronary and extracoronary atherosclerosis in autosomal recessive hypercholesterolemia detected by whole-body computed tomography angiographyMarcello Arca, Fabiana Quagliarini, Giovanni Pigna, et al.
Atherosclerosis|September 7, 2015
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approachIlenia Minicocci, Cristina Prisco, Anna Montali, et al.
Atherosclerosis|February 11, 2011
The relationship between metabolic syndrome, its components, and the whole-body atherosclerotic disease burden as measured by computed tomography angiographyGiovanni Pigna, Alessandro Napoli, Fulvio Zaccagna, et al.
Metabolism: Clinical and Experimental|October 24, 2007
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemiaMarcello Arca, Anna Montali, Giovanni Pigna, et al.
The American Journal of Cardiology|November 13, 2007
Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery diseaseMarcello Arca, Anna Montali, Sofia Valiante, et al.
The Journal of Clinical Endocrinology and Metabolism|June 5, 2012
Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterizationIlenia Minicocci, Anna Montali, Marius Robert Robciuc, et al.
Journal of the American Heart Association|April 23, 2021
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular EventsLaura D'Erasmo, Ilenia Minicocci, Alessia Di Costanzo, et al.
International Journal of Cardiology|June 1, 2013
Functional and morphological vascular changes in subjects with familial combined hypolipidemia: an exploratory analysisIlenia Minicocci, Vito Cantisani, Eleonora Poggiogalle, et al.
Pageof 2